Share Awards, Director Dealings & Issue of Equity

About this update from Duke Capital Limited

Duke Capital Limited 17 August 2026   17 August 2026 Duke Capital Limited   ("Duke Capital", "Duke" or the "Company")   Performance Share Awards Director/PDMR Dealings and Issue of Equity   Duke Capital Limited (AIM: DUKE), a leading provider of hybrid capital solutions for SME business owners in Europe and North America, announces that the Company's Remuneration Committee has approved the grant of a total of 4,589,000 conditional rights to acquire ordinary shares of no par value (“PSAs”) under the Company's Long-Term Incentive Plan ("LTIP").   PSAs for the financial year to 31 March 2026 have been granted as follows:   Neil Johnson 1,222,000 Charlie Cannon Brookes 1,222,000 Other employees (non-PDMRs) 2,145,000 Total 4,589,000   The PSAs vest after a period of three years and are subject to various performance conditions outlined in the Company's admission document (and available on the Company's website) and set by the Remuneration Committee, all in accordance with the LTIP rules. The PSAs will be subject to the following conditions: 25% based on growth in total shareholder return ("TSR"), where TSR can be defined as the returns generated by shareholders based on the combined value of the dividends paid out by the Company and the share price performance over the period in question 25% on growth in total cash available for distribution per share ("TCAD per Share"); and 50% on continuous employment (“Time-based”). The time-based LTIPs will vest equally over three tranches at the end of years 1, 2 and 3.   Vesting of PSAs, transfer from Employee Benefit Trust (“EBT”) & Director/PDMR interests   The Company announces that a total of 453,745 PSAs, previously granted under the Company's LTIP in relation to the financial year ended 31 March 2023 have vested, representing 12.4% of the PSAs granted at that time.   The Company also announces that a total of 772,166 PSAs, previously granted under the Company's LTIP in relation to the financial year ended 31 March 2025 have vested, representing 16.7% of the PSAs granted at that time.   Accordingly, 1,225,911 existing ordinary shares held within the EBT have now been transferred to the beneficiaries, of which 150,000 shares have been sold at a price of approximately 27.55 pence in order to meet certain tax liabilities arising upon issue of the PSAs. Further information is set out within the PDMR notification tables below.   Following the various transactions detailed above, the following Directors / PDMRs have the following total interest in ordinary shares:     Director/PDMR Total ordinary shares held Neil Johnson (1) 8,066,427 Charlie Cannon Brookes (2) 13,637,148     (1)   Mr Johnson is Abingdon Capital Corporation's sole voting shareholder which legally owns 2,123,149 ordinary shares included within this figure.   (2)   Mr Cannon Brookes a Director and shareholder of Arlington Asset Management Limited ("Arlington"). This figure includes 5,818,181 ordinary shares legally owned by Arlington.     Total voting rights and EBT share issue   In order to maintain an appropriate level of headroom within the Company's EBT, the Company has issued 1,552,857 new ordinary shares into the Duke Capital EBT, ownership of which shall be transferred, in part or in full, to individual beneficiaries, subject to achievement of the relevant criteria following the vesting period. Application has been made for these 1,552,857 shares to be admitted to trading on AIM, which is expected to occur on 18 August 2026 ("Admission").     Following Admission and transfer of the 1,225,911 shares to LTIP beneficiaries, the Company will have 511,368,630 ordinary shares in issue admitted to trading on AIM, of which 6,626,313 will be held by the EBT. This figure (511,368,630) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.   For further information, please visit www.dukecapital.com or contact:   Duke Capital Limited Neil Johnson / Charles Cannon Brookes / Hugo Evans   +44 (0) 1481 231 816 Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker) Stephen Keys / Callum Davidson / Michael Johnson   +44 (0) 207 220 0500         Canaccord Genuity Limited (Joint Broker)   Adam James / Harry Rees +44 (0) 207 523 8000   Notifications of dealings by PDMRs:   1. Details of the person discharging managerial responsibilities/persons closely associated a) Name Neil Johnson 2. Reason for notification a) Position/Status Chief Executive Officer b) Initial notification/amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Duke Capital Limited b) LEI 213800GUTKPSJ39SER44 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument and identification code Ordinary shares of nil par value   GG00BYZSSY63 b) Nature of transaction Grant of conditional performance share awards under LTIP c) Price(s) and volume(s) Price(s) Volume(s) N/A 1,222,000 d) Aggregated Information n/a e) Date of transaction Award date: 17 August 2026 f) Place of transaction Outside a trading venue   1. Details of the person discharging managerial responsibilities/persons closely associated a) Name Neil Johnson 2. Reason for notification a) Position/Status Chief Executive Officer b) Initial notification/amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Duke Capital Limited b) LEI 213800GUTKPSJ39SER44 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument and identification code Ordinary shares of nil par value   GG00BYZSSY63 b) Nature of transaction Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP c) Price(s) and volume(s) Price(s) Volume(s) N/A 329,555 d) Aggregated Information n/a e) Date of transaction 17 August 2026 f) Place of transaction Outside a trading venue   1. Details of the person discharging managerial responsibilities/persons closely associated a) Name Neil Johnson 2. Reason for notification a) Position/Status Chief Executive Officer b) Initial notification/amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Duke Capital Limited b) LEI 213800GUTKPSJ39SER44 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument and identification code Ordinary shares of nil par value   GG00BYZSSY63 b) Nature of transaction Sale of ordinary shares following vesting of conditional performance share awards under LTIP to cover tax liability c) Price(s) and volume(s) Price(s) Volume(s) 27.55p per share 150,000     d) Aggregated Information N/A – single transaction e) Date of transaction 14 August 2026 f) Place of transaction London Stock Exchange - AIM   1. Details of the person discharging managerial responsibilities/persons closely associated a) Name Charlie Cannon Brookes 2. Reason for notification a) Position/Status Chief Investment Officer b) Initial notification/amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Duke Capital Limited b) LEI 213800GUTKPSJ39SER44 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument and identification code Ordinary shares of nil par value   GG00BYZSSY63 b) Nature of transaction Grant of conditional performance share awards under LTIP c) Price(s) and volume(s) Price(s) Volume(s) N/A 1,222,000 d) Aggregated Information n/a e) Date of transaction Award date: 17 August 2026 f) Place of transaction Outside a trading venue   1. Details of the person discharging managerial responsibilities/persons closely associated a) Name Charlie Cannon Brookes 2. Reason for notification a) Position/Status Chief Investment Officer b) Initial notification/amendment Initial 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Duke Capital Limited b) LEI 213800GUTKPSJ39SER44 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of the financial instrument, type of instrument and identification code Ordinary shares of nil par value   GG00BYZSSY63 b) Nature of transaction Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP c) Price(s) and volume(s) Price(s) Volume(s) N/A 318,967 d) Aggregated Information n/a e) Date of transaction 17 August 2026 f) Place of transaction Outside a trading venue         This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com . RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy .   END    

View stock analysis, news, and events for Duke Capital Limited